Jeffrey J Colton, MD | |
4550 Investment Dr, 290, Troy, MI 48098-6363 | |
(248) 267-9700 | |
(248) 267-9711 |
Full Name | Jeffrey J Colton |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 4550 Investment Dr, Troy, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912109000 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 4301035310 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jeffrey J Colton, MD 4550 Investment Dr, 290, Troy, MI 48098-6363 Ph: (248) 267-9700 | Jeffrey J Colton, MD 4550 Investment Dr, 290, Troy, MI 48098-6363 Ph: (248) 267-9700 |
News Archive
Researchers at the New York State Department of Health in the United States have said concerning mutations within the B.1.526 lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has recently become prevalent in New York State warrant further monitoring.
Electronic nicotine delivery systems (ENDS), or e-cigarettes, debuted in China in 2003 and have since become available globally, particularly through the Internet. While they resemble traditional tobacco cigarettes, they produce fewer toxins in the vapor for the smoker. Still, these novel products have unknown long-term health and addiction consequences, are of varying nicotine content and delivery, and may appeal to nonusers and youth. ENDS have been banned by health authorities in Canada and Australia.
Technology Catalysts International (TCI), leading global consultants to the pharmaceutical industry, announced that research on cancer trends and development has identified cancer vaccines as a viable treatment option for a variety of cancers that currently have ineffective treatments. The potential of the cancer vaccine market is forecast to approach $3 billion in 2015.
A new study has found that exposure to bright light before bed time inhibits the production of sleep-promoting hormone, melatonin, in preschoolers.
A recent article in the New England Journal of Medicine describes genetic testing of a rare blood cancer called atypical chronic neutrophilic leukemia (CNL) that revealed a new mutation present in most patients with the disease.
› Verified 7 days ago
Ross Mayerhoff, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1560 E Maple Rd, Suite 200, Troy, MI 48083 Phone: 248-581-5200 Fax: 248-581-5299 | |
Dr. Homaira N Danish, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 4600 Investment Dr, Ste 360, Troy, MI 48098 Phone: 248-267-5004 Fax: 248-267-5007 | |
David M Kent, D.O. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 100 Kirts Blvd, Troy, MI 48084 Phone: 248-519-9127 | |
Dr. Ranga Reddy Sirigiri, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 660 Trombley Dr, Troy, MI 48083 Phone: 586-439-5729 | |
Dr. Andrew M Compton, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1639 E Big Beaver Rd Ste 103, Troy, MI 48083 Phone: 248-289-7300 Fax: 248-289-7301 | |
Andrew William Joseph, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3940 John R Rd, Troy, MI 48083 Phone: 947-217-3223 |